Notice of Intent to Sole Source - Lateral Flow Assay Design Using Antibodies Developed... Tender

Procurement Summary

Country : USA

Summary : Notice of Intent to Sole Source - Lateral Flow Assay Design Using Antibodies Developed by the Cdc to Detect Antiretroviral Drugs

Deadline : 26 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 100224637

Document Ref. No. : 000HCKBG-2024-84795

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Contracting Office Address : ATLANTA, GA 30333
Primary Point of Contact : Susanne Cooper
kpz6@cdc.gov

USA
Email :kpz6@cdc.gov

Tender Details

Description

NOTICE OF INTENT TO ISSUE AN ORDER. This is not a request for competitive proposals/quotes. The Centers for Disease Control and Prevention (CDC) hereby announces its intent to issue a sole source order to NanoComposix, Inc. 4878 Ronson Ct., Suite J San Diego, CA for of the procurement of Nanocomposix Lateral flow assay design using antibodies developed by the CDC to detect antiretroviral drugs

The NAICS code for this acquisition is 541713 Research And Development In Nanotechnology

*****

Subject to the Availability of Funds

*****

Nanocomposix Lateral flow assay design using antibodies developed by the CDC to detect antiretroviral drugs

*****

A determination by the Government not to compete this proposed action will be based on responses to this notice and is solely in the discretion of the Contracting Officer. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.

All vendors must be registered in the System for Award Management (SAM) at www.sam.gov, prior to an award of a federal contract.

This action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit quotations.

This is not a request for competitive quotations; however, the Government will review any/all product, capabilities, and pricing information submitted prior to the closure of this notice. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.

Responsible sources that believe they possess the expertise and capabilities identified...
Active Contract Opportunity Notice ID 000HCKBG-2024-84795 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier CENTERS FOR DISEASE CONTROL AND PREVENTION Office CDC OFFICE OF ACQUISITION SERVICES
General Information
Contract Opportunity Type: Presolicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Apr 17, 2024 07:34 am EDT
Original Response Date: Apr 26, 2024 12:00 pm EDT
Inactive Policy: 15 days after response date
Original Inactive Date: May 11, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6850 - MISCELLANEOUS CHEMICAL SPECIALTIES
NAICS Code: 541713 - Research and Development in Nanotechnology

Place of Performance: Atlanta, GA 30329 USA

Documents

 Tender Notice

A13_SSJ_R.pdf